share_log

NeuroSense Therapeutics | 20-F: FY2022 Annual Report

SEC ·  Mar 22, 2023 21:21
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.